Cancer Investigation投稿须知

期刊简介

《Cancer Investigation》是由Informa Healthcare出版社于1983年创办的英文国际期刊（ISSN: 0735-7907，E-ISSN: 1532-4192），该期刊长期致力于肿瘤学领域的创新研究，主要研究方向为医学-肿瘤学。作为SCIE收录期刊（JCR分区 Q3，中科院 4区），本刊采用OA未开放获取模式（OA占比0.0149...%），以发表肿瘤学领域等方向的原创性研究为核心（研究类文章占比83.02%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在53篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Cancer Investigation审稿周期约为约8.5月。该刊近年未被列入国际预警名单，年发文量约53篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
否是否预警
SCIE 期刊收录
53 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 4区	ONCOLOGY 肿瘤学 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 4区	ONCOLOGY 肿瘤学 4区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q3	241 / 322	25.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q4	246 / 322	23.76%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：3.8

SJR：0.604

SNIP：0.472

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q3	217 / 404	46%
大类：Medicine 小类：Cancer Research	Q3	160 / 230	30%

期刊发文

Trends and Projections of Stomach Cancer Incidence in Hong Kong: A Population-Based Study
Author: Yang, Liping; Sun, Haifeng; Bai, Yan; Sun, Shengzhi; Wu, Xiaoming; Gan, Zhenhai; Du, Jianqiang; Du, Jianfei

Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 4, pp. 319-329. DOI: 10.1080/07357907.2022.2126982
Tumoral Overexpression of Hepcidin is Associated with Poor Prognosis of Patients with Clear Cell Renal Cell Carcinoma
Author: Qiu, Huizhu; Gu, Guojian; Zuo, Erdong; Cheng, Xu

Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 1, pp. 84-92. DOI: 10.1080/07357907.2022.2133775
The Prognostic Value of ADAMTS8 and Its Role as a Tumor Suppressor in Breast Cancer
Author: Zhang, Qia; Kanyomse, Quist; Luo, Chenghao; Mo, Qingfan; Zhao, XunPing; Wang, Long; Peng, Weiyan; Ren, Guosheng

Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 2, pp. 119-132. DOI: 10.1080/07357907.2022.2128367
A DNA Damage Response Related Signature to Predict Prognosis in Patients with Acute Myeloid Leukemia
Author: Wang, Jun; Wu, Jiafei; Wang, Yijing; Wang, Yu; Jiang, Chuanyan; Zou, Mengying; Jin, Xiaokang; Sun, Xiaoran; Zhang, Yu; Ma, Sijia; Wang, Guoqiang; Zhu, Xin; Lu, Huafei; Xu, Chunwei; Wang, Wenxian; Li, Leo; Han, Yusheng; Cai, Shangli; Li, Hui

Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 3, pp. 271-283. DOI: 10.1080/07357907.2023.2167209
Efficacy and Safety of Bevacizumab for Treating Glioblastoma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled Trials
Author: Xie, Xiaohong; Bao, Shangyi; Zhao, Hong; Li, Liuying; Fu, Xiaojun

Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 3, pp. 305-317. DOI: 10.1080/07357907.2023.2174261
Poorly Controlled Diabetes Mellitus Increases the Risk of Deaths and Castration-Resistance in Locally Advanced Prostate Cancer Patients
Author: Ma, Cheng; Cui, Di; Han, Bangmin; Ding, Mao; Zhang, Jiahao; Liu, Shiyun; Gao, Yingli; Xia, Shujie

Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 4, pp. 345-353. DOI: 10.1080/07357907.2023.2171050
Identification and Validation of Molecular Subtype and Prognostic Signature for Bladder Cancer Based on Neutrophil Extracellular Traps
Author: Tu, Yaofen; Mao, Zujie

Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 4, pp. 354-368. DOI: 10.1080/07357907.2023.2179063
Bioinformatics Identification and Validation of Aging-Related Molecular Subtype and Prognostic Signature in Sarcoma
Author: Hong, Xu; Liu, Hui; Chen, Chu; Lai, Tian; Lin, Jingui

Journal: CANCER INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1080/07357907.2023.2209638

Cancer Investigation

癌症调查

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询